Browsing by Author Baumann, Tycho

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)
24-Jun-2014Chronic lymphocytic leukemia in the elderly: clinico-biological features, outcomes, and proposal of a prognostic model.Baumann, Tycho; Delgado, Julio (Delgado González); Santacruz, Rodrigo; Martínez-Trillos, Alejandra; Royo Moreno, Cristina; Navarro López, Alba; Pinyol, Magda; Rozman, María; Pereira Saavedra, Arturo; Villamor i Casas, Neus; Aymerich Gregorio, Marta; López Alcalá, Cristina; Carrió, Ana; Montserrat Costa, Emilio
6-Dec-2018Development of a novel anti-CD19 chimeric antigen receptor: A paradigm for an affordable CAR T cell production at academic institutionsCastella, Maria; Boronat, Anna; Martín-Ibáñez, Raquel; Rodríguez, Vanina; Suñé, Guillermo; Caballero, Miguel; Marzal, Berta; Pérez-Amill, Lorena; Martín-Antonio, Beatriz; Castaño, Julio; Bueno, Clara; Balagué, Olga; González-Navarro, Europa Azucena; Serra Pagès, Carles; Engel Rocamora, Pablo; Vilella, Ramon; Benítez Ribas, Daniel; Ortiz-Maldonado, Valentín; Cid Vidal, Joan; Tabera, Jaime; Canals i Coll, Josep M.; Lozano, Miquel; Baumann, Tycho; Vilarrodona, Anna; Trias, Esteve; Campo Güerri, Elias; Menendez, Pablo; Urbano Ispizua, Álvaro; Yagüe, Jordi; Pérez Galán, Patricia; Rives, Susana; Delgado, Julio; Juan, Manel
Nov-2014Genomic complexity and IGHV mutational status are key predictors of outcome of chronic lymphocytic leukemia patients with TP53 disruption.Delgado, Julio (Delgado González); Salaverria Frigola, Itziar; Baumann, Tycho; Martínez Trillos, Alejandra; Lee, Eriong; Jiménez, Laura; Navarro López, Alba; Royo Moreno, Cristina; Santacruz, Rodrigo; López, Cristina; Payer, Ángel R.; Colado, Enrique; González, Marcos; Armengol, Lluís; Colomer Pujol, Dolors; Pinyol, Magda; Villamor i Casas, Neus; Aymerich Gregorio, Marta; Carrió, Ana; Costa, Dolors; Clot, Guillem; Giné Soca, Eva; López Guillermo, Armando; Campo Güerri, Elias; Beà Bobet, Sílvia M.
Mar-2019Mutations in RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemiaGiménez, Neus; Martínez-Trillos, Alejandra; Montraveta, Arnau; Lopez Guerra, Mónica; Rosich, Laia; Nadeu, Ferran; Valero, Juan G.; Aymerich Gregorio, Marta; Magnano, Laura; Rozman, María; Matutes, Estella; Delgado, Julio; Baumann, Tycho; Gine, Eva; González, Marcos; Alcoceba, Miguel; Terol, M.José; Navarro, Blanca; Colado, Enrique; Payer, Angel R.; Puente, Xose S.; López Otín, Carlos; López-Guillermo, Armando; Campo Güerri, Elias; Colomer Pujol, Dolors; Villamor i Casas, Neus